View Future GrowthHEXPOL 過去の業績過去 基準チェック /16HEXPOLの収益は年間平均-1.2%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間8% 4.8%割合で 増加しています。 HEXPOLの自己資本利益率は12.3%であり、純利益率は9.9%です。主要情報-1.23%収益成長率-1.23%EPS成長率Chemicals 業界の成長23.20%収益成長率4.78%株主資本利益率12.35%ネット・マージン9.88%次回の業績アップデート20 Jul 2026最近の業績更新Reported Earnings • May 05First quarter 2026 earnings released: EPS: kr1.47 (vs kr1.75 in 1Q 2025)First quarter 2026 results: EPS: kr1.47 (down from kr1.75 in 1Q 2025). Revenue: kr4.77b (down 11% from 1Q 2025). Net income: kr507.0m (down 16% from 1Q 2025). Profit margin: 11% (in line with 1Q 2025). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy.Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.5% growth forecast for the Chemicals industry in Italy.Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% growth forecast for the Chemicals industry in Italy.Reported Earnings • Oct 27Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024)Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.7% growth forecast for the Chemicals industry in Italy.お知らせ • Oct 24+ 2 more updatesHEXPOL AB (publ) to Report Nine Months, 2026 Results on Oct 23, 2026HEXPOL AB (publ) announced that they will report nine months, 2026 results on Oct 23, 2026Reported Earnings • Jul 20Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024)Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.すべての更新を表示Recent updatesBoard Change • May 18Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Henrik Elmin was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • May 05First quarter 2026 earnings released: EPS: kr1.47 (vs kr1.75 in 1Q 2025)First quarter 2026 results: EPS: kr1.47 (down from kr1.75 in 1Q 2025). Revenue: kr4.77b (down 11% from 1Q 2025). Net income: kr507.0m (down 16% from 1Q 2025). Profit margin: 11% (in line with 1Q 2025). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy.Board Change • May 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.5% growth forecast for the Chemicals industry in Italy.Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% growth forecast for the Chemicals industry in Italy.お知らせ • Jan 30+ 1 more updateHEXPOL AB (publ), Annual General Meeting, May 04, 2026HEXPOL AB (publ), Annual General Meeting, May 04, 2026.Reported Earnings • Oct 27Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024)Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.7% growth forecast for the Chemicals industry in Italy.お知らせ • Oct 24+ 2 more updatesHEXPOL AB (publ) to Report Nine Months, 2026 Results on Oct 23, 2026HEXPOL AB (publ) announced that they will report nine months, 2026 results on Oct 23, 2026お知らせ • Sep 22Hexpol AB (Publ) Announces President Changes for Hexpol Compounding Americas, Effective September 19, 2025HEXPOL AB (publ) has appointed Kenneth Bloom as interim President of HEXPOL Compounding Americas effective September 19, 2025. Kenneth Bloom succeeds Gary Moore, who will leave the company September 19, 2025. Kenneth Bloom will act as interim President until a permanent successor has been appointed. Kenneth has previously held the position as President of HEXPOL Compounding Americas between 2020 and 2022 and before that has some 20 years of experience within the polymer industry.Reported Earnings • Jul 20Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024)Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.お知らせ • Jun 17HEXPOL AB (publ) to Report Q4, 2025 Results on Jan 29, 2026HEXPOL AB (publ) announced that they will report Q4, 2025 results on Jan 29, 2026お知らせ • May 01HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler.HEXPOL AB (publ) (OM:HPOL B) has signed an agreement to acquire 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler for €54 million on February 18, 2025. The acquisition price amounts to 54 MEUR on a cash and debt free basis and is funded by a combination of bank facilities and cash. The closing will take place after regulatory approvals. HEXPOL has an option toacquire the remaining shares, and the founders have an option to sell their remaining shares to HEXPOL. For the period ending December 31, 2024, KABKOM Kimya Sanayi ve Ticaret A.S. reported total revenue of €30 million. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler on April 30, 2025.お知らせ • Apr 26Hexpol AB (Publ) Approves Dividend for Financial Year 2024HEXPOL AB (publ) at its AGM held on April 25, 2025, resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 4.20 per share be declared for the financial year 2024 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 29, 2025.お知らせ • Apr 10HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta.HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025. In line with the communication at the time of acquisition of almaak in 2022, the option to purchase the remaining 30% of almaak is now exercised. Current management will remain with the company. The transaction takes place on 9 April 2025 and will be included in the second quarter of 2025. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025.Valuation Update With 7 Day Price Move • Apr 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €8.14, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €15.88 per share.Reported Earnings • Mar 26Full year 2024 earnings released: EPS: kr6.45 (vs kr7.33 in FY 2023)Full year 2024 results: EPS: kr6.45 (down from kr7.33 in FY 2023). Revenue: kr20.4b (down 7.3% from FY 2023). Net income: kr2.22b (down 12% from FY 2023). Profit margin: 11% (in line with FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Italy.お知らせ • Jan 29HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025. Location: malmo Sweden収支内訳HEXPOL の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BIT:1HPOL 収益、費用、利益 ( )SEK Millions日付収益収益G+A経費研究開発費31 Mar 2618,7111,8481,17614831 Dec 2519,3241,9431,16814830 Sep 2519,7641,9571,11513630 Jun 2520,0492,0511,10013631 Mar 2520,5062,1681,05913631 Dec 2420,4372,2201,01713630 Sep 2420,6112,3741,02615230 Jun 2421,0952,4851,05715231 Mar 2421,3682,5101,07115231 Dec 2322,0462,5241,09615230 Sep 2322,6732,6411,08413730 Jun 2323,1332,5861,05213731 Mar 2323,0602,5511,01713731 Dec 2222,2432,48394613730 Sep 2220,8332,30591511130 Jun 2219,0202,53181811131 Mar 2217,3682,42472311131 Dec 2116,0052,35869811130 Sep 2115,3222,3687419730 Jun 2114,5421,9537639731 Mar 2113,0661,5388049731 Dec 2013,4241,4099049730 Sep 2013,7961,28997110530 Jun 2014,7121,2181,03010531 Mar 2015,8711,5091,01810531 Dec 1915,5081,54294210530 Sep 1915,2911,6118259930 Jun 1914,4901,6607559931 Mar 1914,2661,6737299931 Dec 1813,7701,6466869930 Sep 1813,1391,6906479130 Jun 1812,6321,6196149131 Mar 1812,4011,5596089131 Dec 1712,2301,5275929130 Sep 1712,0571,4526078230 Jun 1711,8631,4586078231 Mar 1711,2601,4215918231 Dec 1610,8791,3975858230 Sep 1610,7221,3495887830 Jun 1610,7521,3685687831 Mar 1611,0351,3965567831 Dec 1511,2291,3935437830 Sep 1510,9641,3155656430 Jun 1510,5041,23754264質の高い収益: 1HPOLは 高品質の収益 を持っています。利益率の向上: 1HPOLの現在の純利益率 (9.9%)は、昨年(10.6%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 1HPOLの収益は過去 5 年間で年間1.2%減少しました。成長の加速: 1HPOLは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: 1HPOLは過去 1 年間で収益成長率がマイナス ( -14.8% ) となったため、 Chemicals業界平均 ( -36.9% ) と比較することが困難です。株主資本利益率高いROE: 1HPOLの 自己資本利益率 ( 12.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 22:22終値2026/05/27 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋HEXPOL AB (publ) 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関null nullABG Sundal CollierAndres Castanos-MollorBerenbergFabian WeinstockBerenberg7 その他のアナリストを表示
Reported Earnings • May 05First quarter 2026 earnings released: EPS: kr1.47 (vs kr1.75 in 1Q 2025)First quarter 2026 results: EPS: kr1.47 (down from kr1.75 in 1Q 2025). Revenue: kr4.77b (down 11% from 1Q 2025). Net income: kr507.0m (down 16% from 1Q 2025). Profit margin: 11% (in line with 1Q 2025). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy.
Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.5% growth forecast for the Chemicals industry in Italy.
Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% growth forecast for the Chemicals industry in Italy.
Reported Earnings • Oct 27Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024)Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.7% growth forecast for the Chemicals industry in Italy.
お知らせ • Oct 24+ 2 more updatesHEXPOL AB (publ) to Report Nine Months, 2026 Results on Oct 23, 2026HEXPOL AB (publ) announced that they will report nine months, 2026 results on Oct 23, 2026
Reported Earnings • Jul 20Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024)Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.
Board Change • May 18Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Henrik Elmin was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • May 05First quarter 2026 earnings released: EPS: kr1.47 (vs kr1.75 in 1Q 2025)First quarter 2026 results: EPS: kr1.47 (down from kr1.75 in 1Q 2025). Revenue: kr4.77b (down 11% from 1Q 2025). Net income: kr507.0m (down 16% from 1Q 2025). Profit margin: 11% (in line with 1Q 2025). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy.
Board Change • May 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.5% growth forecast for the Chemicals industry in Italy.
Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% growth forecast for the Chemicals industry in Italy.
お知らせ • Jan 30+ 1 more updateHEXPOL AB (publ), Annual General Meeting, May 04, 2026HEXPOL AB (publ), Annual General Meeting, May 04, 2026.
Reported Earnings • Oct 27Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024)Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.7% growth forecast for the Chemicals industry in Italy.
お知らせ • Oct 24+ 2 more updatesHEXPOL AB (publ) to Report Nine Months, 2026 Results on Oct 23, 2026HEXPOL AB (publ) announced that they will report nine months, 2026 results on Oct 23, 2026
お知らせ • Sep 22Hexpol AB (Publ) Announces President Changes for Hexpol Compounding Americas, Effective September 19, 2025HEXPOL AB (publ) has appointed Kenneth Bloom as interim President of HEXPOL Compounding Americas effective September 19, 2025. Kenneth Bloom succeeds Gary Moore, who will leave the company September 19, 2025. Kenneth Bloom will act as interim President until a permanent successor has been appointed. Kenneth has previously held the position as President of HEXPOL Compounding Americas between 2020 and 2022 and before that has some 20 years of experience within the polymer industry.
Reported Earnings • Jul 20Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024)Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.
お知らせ • Jun 17HEXPOL AB (publ) to Report Q4, 2025 Results on Jan 29, 2026HEXPOL AB (publ) announced that they will report Q4, 2025 results on Jan 29, 2026
お知らせ • May 01HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler.HEXPOL AB (publ) (OM:HPOL B) has signed an agreement to acquire 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler for €54 million on February 18, 2025. The acquisition price amounts to 54 MEUR on a cash and debt free basis and is funded by a combination of bank facilities and cash. The closing will take place after regulatory approvals. HEXPOL has an option toacquire the remaining shares, and the founders have an option to sell their remaining shares to HEXPOL. For the period ending December 31, 2024, KABKOM Kimya Sanayi ve Ticaret A.S. reported total revenue of €30 million. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler on April 30, 2025.
お知らせ • Apr 26Hexpol AB (Publ) Approves Dividend for Financial Year 2024HEXPOL AB (publ) at its AGM held on April 25, 2025, resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 4.20 per share be declared for the financial year 2024 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 29, 2025.
お知らせ • Apr 10HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta.HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025. In line with the communication at the time of acquisition of almaak in 2022, the option to purchase the remaining 30% of almaak is now exercised. Current management will remain with the company. The transaction takes place on 9 April 2025 and will be included in the second quarter of 2025. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025.
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €8.14, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €15.88 per share.
Reported Earnings • Mar 26Full year 2024 earnings released: EPS: kr6.45 (vs kr7.33 in FY 2023)Full year 2024 results: EPS: kr6.45 (down from kr7.33 in FY 2023). Revenue: kr20.4b (down 7.3% from FY 2023). Net income: kr2.22b (down 12% from FY 2023). Profit margin: 11% (in line with FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Italy.
お知らせ • Jan 29HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025. Location: malmo Sweden